Stevard LLC’s Editas Medicine EDIT Stock Holding History

Stevard LLC’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,759	Closed	-$246K	–	96
2020 Q3	$246K	Buy	8,759 +1,559	+22%	+$50.8K	0.1%	136
2020 Q2	$213K	Buy	+7,200	New	+$188K	0.11%	141

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Stevard LLC's EDIT Position: Q4 2020 in Review

Stevard LLC sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 8,759 shares — an estimated $246K sold.

Stevard LLC first reported a position in EDIT in Q2 2020 and held it in 2 quarters. The position peaked at $246K in Q3 2020. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

Stevard LLC reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
Stevard LLC sold 8,759 Editas Medicine shares in Q4 2020, an estimated $246K.
Stevard LLC first reported a position in Editas Medicine in Q2 2020 and held it in 2 quarters.
Stevard LLC's Editas Medicine position peaked at $246K in Q3 2020.
311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Stevard LLC's 13F filing for Q4 2020, filed 12 Feb 2021.